4-(2-(BUTYLNITROSOAMINO)-1-HYDROXYETHYL)-6-DIAZO-2,4-CYCLOHEXADIEN-1-ONE, (R)-
UNII NZ35Q9NX7K
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-(butylnitrosoamino)-1-hydroxyethyl)-6-diazo-2,4-cyclohexadien-1-one, (r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NZ35Q9NX7K.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 108333-74-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C12H16N4O3 XCTWLIUNPSHBSS-LBPRGKRZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-(butylnitrosoamino)-1-hydroxyethyl)-6-diazo-2,4-cyclohexadien-1-one, (r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.